Opportunities for Collaborative Research at the NIH Clinical Center (U01)

Funding Opportunity Announcement (FOA) Number
PAR-13-358

Companion Funding Opportunity
PAR-13-357, X02 Pre-application

Number of Applications
See Section III. 3. Additional Information on Eligibility.

Catalog of Federal Domestic Assistance (CFDA) Number(s)
93.865; 93.233; 93.839; 93.838; 93.837; 93.286; 93.856; 93.855; 93.273; 93.173; 93.399; 93.396; 93.395; 93.394; 93.393; 93.172; 93.279; 93.879  

Funding Opportunity Purpose
The goal of this program is to support collaborative translational research projects aligned with NIH efforts to enhance the translation of basic biological discoveries into clinical applications that improve health.  It encourages high quality science demonstrating the potential to result in understanding an important disease process or lead to new therapeutic interventions, diagnostics, or prevention strategies within the research interests and priorities of the participating NIH Institutes/Centers (ICs).

Specifically, the program seeks to broaden and strengthen translational research collaborations between basic and clinical researchers both within and outside NIH to accelerate and enhance translational science by promoting partnerships between NIH intramural investigators (e.g., those conducting research within the labs and clinics of the NIH) and extramural investigators (e.g., those conducting research in labs outside the NIH), and by providing support for extramural investigators to take advantage of the unique research opportunities available at the NIH Clinical Center by conducting research projects in collaboration with NIH intramural investigators.

In order to be eligible for this program, the application must include at least one intramural scientist as Program Director/Principal Investigator or collaborator, and at least some of the research must be conducted at the NIH Clinical Center.  Through this collaboration, external researchers may gain access to the NIH Clinical Center and leverage the diverse Clinical Center resources, expertise, and infrastructure available to test promising laboratory- and animal-based discoveries with potential for advancing disease diagnosis, treatment and prevention.  The special environment of the Clinical Center can support studies that may not be readily supported elsewhere.

The companion FOA (PAR-13-357) encourages X02 pre-applications for Opportunities for Collaborative Research at the NIH Clinical Center.  The X02 pre-application is the recommended (not required) first step in the application process for this FOA.  Potential applicants should read both FOAs.  Investigators whose X02 pre-applications are meritorious, can be supported by the resources of the NIH Clinical Center, and align with the research missions of the participating NIH ICs, will be notified of the opportunity to submit a U01 application to this FOA.

Key Dates
Posted Date
September  20, 2013

Open Date (Earliest Submission Date)
February 20, 2014

Letter of Intent Due Date(s)
30 days prior to the application due date.  Applicants are encouraged to submit an X02 pre-application, as described in the companion FOA (PAR-13-357).  Applicants who submit an X02 pre-application should not submit a Letter of Intent.

Application Due Date(s)
March 20, 2014, March 20, 2015, by 5:00 PM local time of applicant organization.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s)
March 20, 2014, March 20, 2015, by 5:00 PM local time of applicant organization.

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.